Range of medical conditions including Tendinopathy, Arthropathy, Osteoarthritis (knee) and muscular distractions in both acute and chronic status. Musculoskeletal Diseases Range of medical conditions including Tendinopathy, Arthropathy, Osteoarthritis (knee) and muscular distractions in both acute and chronic status.
Conditions
Interventions
The research centre enrolls over 300 patients for a 12 month period and incorporates 6 primary efficacy variables of patients’ pain, patients function and physician global evaluation- patients’ condit
angiosome, myotomes and viscera an area of skin and underlying tissues, muscles and abdomen followed with Thermal Radiofrequency and Athermal Radiofrequency (Fraxelling) and Low Frequency Ultrasound a
otherwise study worksheet is created, signed and dated by delegated investigators to work as source document. The investigator clearly marks clinical records to indicate that the subject is enrolled i
Sponsors
iMed Group International Ltd
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Aged 18 to 80 years 2. Any of the following pathologies: tendinopathy, arthropathy, muscular distractions, osteoarthritis and rheumatoid arthritis 3. Not receiving any other therapy for the duration of clinical program
Exclusion criteria
Exclusion criteria: 1. Cardiac Pace Makers 2. Defibrillators 3. Primary non treated epilepsy 4. Cemented metal replacement surgery (dental implants acceptable) 5. Non diagnosed pain 6. Not able to communicate sensation of pain to therapist 7. Psychological issues 8. Cancer under active treatment 9. Active Tuberculosis 10. Immunological diseases of skin 11. Lateral arthertrophic sclerosis (ALS) 12. Doubtful medical history 13. Active thrombophlebitis 14. Pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain level is measured on the Visual Analogue Scale at baseline and after the end of the required number of MTS Sessions (1 to 3 weeks) | — |
Secondary
| Measure | Time frame |
|---|---|
| The exploratory analyses listed below are planned but may not be conducted if deemed to be obsolete during later stages of the trial; other exploratory analyses may be added. 1. Overall efficacy of MTS for tissue rehabilitation is measured using stretching exercises at baseline and 3-9 months 2. Pain relief for both acute and chronic cases is measured using VAS at baseline and 3-9 months 3. Speed of rehabilitation is measured using strengthening exercises at baseline and 3-9 months 4. Quality of Life for chronic sufferers is measured using activities of daily living (ADL) at baseline and 3-9 months 5. Range of motion after injury (acute or chronic) is measured using ergonomic assessment tools at baseline and 3-9 months 6. Safety of the therapy is evaluated by assessing adverse body effects or side effects throughout the study | — |
Countries
India, United Kingdom
Outcome results
None listed